Figure 2.

Cumulative incidence of acute kidney injury (AKI) as proportion of patients without AKI according different criteria by different stages in relation to ICU Days in 57 patients included in a prospective observational study of AKI incidence and biomarker profile in patients admitted with severe COVID‐19 in a tertiary ICU at a University Hospital in Sweden. Proportions are illustrated according to classification by (A) combined KDIGO criteria (B) KDIGO Creatinine criteria only and (C) KDIGO Urine Output criteria only (N = 53)